Skip to main content
Top
Published in: Rheumatology International 5/2018

01-05-2018 | Observational Research

Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables

Authors: Carolina Baeza-Velasco, Caroline Bourdon, Lucile Montalescot, Cécile de Cazotte, Guillem Pailhez, Antonio Bulbena, Claude Hamonet

Published in: Rheumatology International | Issue 5/2018

Login to get access

Abstract

Despite the frequent co-ocurrence of hypermobile Ehler–Danlos syndrome (hEDS) and pathological anxiety, little is known about the psychosocial and health implications of such comorbidity. Our aim was to explore the association between high levels of anxiety and psychosocial (catastrophizing, kinesiophobia, somatosensory amplification, social support and functioning), health (pain, fatigue, BMI, tobacco/alcohol use, depression, diagnosis delay, general health), and sociodemographic factors in people with hEDS. In this cross-sectional study, 80 hEDS patients were divided into two groups according to self-reported anxiety levels: low and high. Psychosocial, sociodemographic and health variables were compared between the groups. Forty-one participants reported a high level of anxiety (51.2%). No differences were found in the sociodemographic variables between high-anxious and low-anxious patients. The percentage of participants with severe fatigue and high depressive symptomatology was significantly higher in the high-anxious group (80.5 vs 56.4; 26.8 vs 12.8%, respectively). High-anxious hEDS patients also showed significantly higher levels of pain catastrophizing, somatosensory amplification as well as a poorer social functioning and general health. Multivariate analyses showed that somatosensory amplification, pain catastrophizing and poor social functioning are variables that increase the probability of belonging to the high-anxious group. Despite limitations, this first study comparing high-anxious versus low-anxious hEDS patients with respect to health aspects, highlight the importance of considering the psychosocial factors (many susceptible to modification), to improve the adjustment to this chronic condition and provide support to those affected through a biopsychosocial approach.
Literature
1.
go back to reference Malfait F, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavalle ME, Levy H, Mendoza-Londono R, Pepin M, Pope M, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GL, Van Damme T, Vandersteen A, Van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification on the Ehlers–Danlos syndromes. Am J Med Genet 175C:148–157 Malfait F, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavalle ME, Levy H, Mendoza-Londono R, Pepin M, Pope M, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GL, Van Damme T, Vandersteen A, Van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification on the Ehlers–Danlos syndromes. Am J Med Genet 175C:148–157
2.
go back to reference Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37CrossRefPubMed Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37CrossRefPubMed
3.
go back to reference Steinmann B, Royce PM, Superti-Furga A (2002) The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 431–524CrossRef Steinmann B, Royce PM, Superti-Furga A (2002) The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 431–524CrossRef
4.
go back to reference Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers–Danlos Syndrome (a.k.a. Ehlers–Danlos syndrome type III and Ehlers–Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet 175C:48–69CrossRef Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers–Danlos Syndrome (a.k.a. Ehlers–Danlos syndrome type III and Ehlers–Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet 175C:48–69CrossRef
5.
go back to reference Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed
6.
go back to reference Tinkle BT, Bird HA Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet 149A:2368–2370CrossRefPubMed Tinkle BT, Bird HA Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet 149A:2368–2370CrossRefPubMed
7.
go back to reference Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet 169C:6–22CrossRefPubMed Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet 169C:6–22CrossRefPubMed
8.
go back to reference Hamonet C, Gompel A, Raffray Y, Zeitoun JD, Delarue M, Vlamynck E, Haidar R, Mazaltarine G (2014) Multiple pains in Ehlers–Danlos syndrome. Description and proposal of a therapy protocol. Douleurs 15:264–277. https://doi.org/10.1016/j.douler Hamonet C, Gompel A, Raffray Y, Zeitoun JD, Delarue M, Vlamynck E, Haidar R, Mazaltarine G (2014) Multiple pains in Ehlers–Danlos syndrome. Description and proposal of a therapy protocol. Douleurs 15:264–277. https://​doi.​org/​10.​1016/​j.​douler
9.
go back to reference Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Pract Rheumatol 4:522–524CrossRefPubMed Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Pract Rheumatol 4:522–524CrossRefPubMed
10.
go back to reference Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL, Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP, Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe M (2009) Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9:883–891. https://doi.org/10.1016/j.jpain.2008.05.005 CrossRef Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL, Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP, Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe M (2009) Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9:883–891. https://​doi.​org/​10.​1016/​j.​jpain.​2008.​05.​005 CrossRef
11.
go back to reference Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, Pailhez G, Critchley H, Chopra P, Mallorqui-Bagué N, Frank Ch, Porges S (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndrome. Am J Med Genet 175C:237–245CrossRef Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, Pailhez G, Critchley H, Chopra P, Mallorqui-Bagué N, Frank Ch, Porges S (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndrome. Am J Med Genet 175C:237–245CrossRef
13.
15.
go back to reference Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Bravo JF (2011) Joint hypermobility syndrome: problems that require psychological intervention. Rheumatol Int 31:1131–1136CrossRefPubMed Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Bravo JF (2011) Joint hypermobility syndrome: problems that require psychological intervention. Rheumatol Int 31:1131–1136CrossRefPubMed
16.
go back to reference Berglund B, Anne-Cathrine M, Randers I (2010) Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil 32:1–7CrossRefPubMed Berglund B, Anne-Cathrine M, Randers I (2010) Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil 32:1–7CrossRefPubMed
17.
go back to reference Berglund B, Nordström G, Lützén K (2000) Living a restricted life with Ehlers–Danlos syndrome (EDS). Int J Nurs Stud 37:111–118CrossRefPubMed Berglund B, Nordström G, Lützén K (2000) Living a restricted life with Ehlers–Danlos syndrome (EDS). Int J Nurs Stud 37:111–118CrossRefPubMed
18.
go back to reference Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A (2015) Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 37:24–30CrossRefPubMed Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A (2015) Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 37:24–30CrossRefPubMed
19.
go back to reference Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, Armengol L, Ponsa I, Miro R, Bulbena A, Estivill X (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379CrossRefPubMed Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, Armengol L, Ponsa I, Miro R, Bulbena A, Estivill X (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379CrossRefPubMed
20.
go back to reference Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Fénétrier C, Bravo JF (2011) Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med 41:187–201CrossRefPubMed Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Fénétrier C, Bravo JF (2011) Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med 41:187–201CrossRefPubMed
23.
go back to reference Mallorqui-Bagué N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, Critchley HD (2014) Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol 5:1162PubMedPubMedCentral Mallorqui-Bagué N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, Critchley HD (2014) Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol 5:1162PubMedPubMedCentral
24.
go back to reference Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed
25.
go back to reference Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Dis 15:53–79CrossRef Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Dis 15:53–79CrossRef
28.
go back to reference Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers–Danlos syndrome. J Pediatr 135:494–499CrossRefPubMed Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers–Danlos syndrome. J Pediatr 135:494–499CrossRefPubMed
29.
go back to reference De Wandele I, Rombaut L, De Backer T, Peersman W, Da Silva H, De Mits S, De Paepe A, Calders P, Malfait F (2016) Orthostatic intolerance and fatigue in the hypermobile type of Ehlers–Danlos syndrome. Rheumatology 55(8):1412–1420CrossRefPubMed De Wandele I, Rombaut L, De Backer T, Peersman W, Da Silva H, De Mits S, De Paepe A, Calders P, Malfait F (2016) Orthostatic intolerance and fatigue in the hypermobile type of Ehlers–Danlos syndrome. Rheumatology 55(8):1412–1420CrossRefPubMed
30.
go back to reference Hakim A, De Wandele I, O’Callaghan C, Pocinki A, Rowe P (2017) Chronic fatigue in Ehlers–Danlos syndrome-hypermobility type. Am J Med Genet 175C:175–180CrossRef Hakim A, De Wandele I, O’Callaghan C, Pocinki A, Rowe P (2017) Chronic fatigue in Ehlers–Danlos syndrome-hypermobility type. Am J Med Genet 175C:175–180CrossRef
32.
go back to reference Zeitoun J-D, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C (2013) Functional digestive symptoms and quality of life in patients with Ehlers– Danlos syndromes: results of a national cohort study on 134 patients. PLoS One 8:e80321CrossRefPubMedPubMedCentral Zeitoun J-D, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C (2013) Functional digestive symptoms and quality of life in patients with Ehlers– Danlos syndromes: results of a national cohort study on 134 patients. PLoS One 8:e80321CrossRefPubMedPubMedCentral
33.
go back to reference Zigmond A. Snaith R (1983) The hospital anxiety and depression scale. Acta Psiquiatr Scand 67:361–370CrossRef Zigmond A. Snaith R (1983) The hospital anxiety and depression scale. Acta Psiquiatr Scand 67:361–370CrossRef
34.
go back to reference Lépine JP, Godchau M, Brun P, Lemperière T (1985) Evaluation de l’anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Annales Médico Psychologiques 43:175–189 Lépine JP, Godchau M, Brun P, Lemperière T (1985) Evaluation de l’anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Annales Médico Psychologiques 43:175–189
35.
go back to reference Sarason IG, Levine HM, Basham RB, Sarason BR (1983) Assessing social support: the social support questionnaire. J Pers Soc Psychol 44:127–139CrossRef Sarason IG, Levine HM, Basham RB, Sarason BR (1983) Assessing social support: the social support questionnaire. J Pers Soc Psychol 44:127–139CrossRef
36.
go back to reference Rascle N, Bruchon-Schweitzer M, Sarason IG (2005) Short form of Saranson’s Social Support Questionnaire: French adaptation and validation. Psychol Reports 97:195–202CrossRef Rascle N, Bruchon-Schweitzer M, Sarason IG (2005) Short form of Saranson’s Social Support Questionnaire: French adaptation and validation. Psychol Reports 97:195–202CrossRef
37.
go back to reference Miller R, Kori S, Todd D (1991) The Tampa Scale for Kinesiophobia, Tampa, FL. (Unpublished report) Miller R, Kori S, Todd D (1991) The Tampa Scale for Kinesiophobia, Tampa, FL. (Unpublished report)
38.
go back to reference French DJ, Roach PJ, Mayes S (2002) Peur du movement chez les accidentés du travail: l’Echelle de Kinesiophobie de Tampa (EKT). Can J Behav Sci 34:28–33CrossRef French DJ, Roach PJ, Mayes S (2002) Peur du movement chez les accidentés du travail: l’Echelle de Kinesiophobie de Tampa (EKT). Can J Behav Sci 34:28–33CrossRef
39.
go back to reference Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–324CrossRefPubMed Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–324CrossRefPubMed
41.
go back to reference Köteles F, Doering BK (2015) The many faces of somatosensory amplification: the relative contribution of body awareness, symptom labeling, and anxiety. J health Psychol 21:2903–2911CrossRefPubMed Köteles F, Doering BK (2015) The many faces of somatosensory amplification: the relative contribution of body awareness, symptom labeling, and anxiety. J health Psychol 21:2903–2911CrossRefPubMed
42.
go back to reference French DJ, Noël M, Vigneau F (2005) L’echelle de dramatization face à la douleur PCS-CF: adaptation canadienne en langue française de l’echelle “Pain Catastrohpizing Scale”. Can J Behav Sci 37:181–192CrossRef French DJ, Noël M, Vigneau F (2005) L’echelle de dramatization face à la douleur PCS-CF: adaptation canadienne en langue française de l’echelle “Pain Catastrohpizing Scale”. Can J Behav Sci 37:181–192CrossRef
43.
go back to reference McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 31:247–263CrossRefPubMed McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 31:247–263CrossRefPubMed
44.
go back to reference Leplège A, Ecosse E, Verdier A, Perneger TV (1998) The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51:1013–1023CrossRefPubMed Leplège A, Ecosse E, Verdier A, Perneger TV (1998) The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51:1013–1023CrossRefPubMed
45.
go back to reference Bulbena A, Pailhez G, Bulbena-Cabré A, Mallorqui-Bagué N, Baeza-Velasco C (2015) Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a bew phenotype. Adv Psychosom Med 34:143–157CrossRefPubMed Bulbena A, Pailhez G, Bulbena-Cabré A, Mallorqui-Bagué N, Baeza-Velasco C (2015) Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a bew phenotype. Adv Psychosom Med 34:143–157CrossRefPubMed
46.
go back to reference Murray B, Yashar BM, Uhlmann WR, Clauw DJ, Petty EM (2013) Ehlers–Danlos syndrome, hypermobility type: a characterization of the patients’ lived experience. Am J Med Genet 161A:2981–2988CrossRefPubMed Murray B, Yashar BM, Uhlmann WR, Clauw DJ, Petty EM (2013) Ehlers–Danlos syndrome, hypermobility type: a characterization of the patients’ lived experience. Am J Med Genet 161A:2981–2988CrossRefPubMed
47.
go back to reference Berglund B, Petterson C, Pigg M, Kristiansson (2015) Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskeletal Disord 16:89CrossRef Berglund B, Petterson C, Pigg M, Kristiansson (2015) Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskeletal Disord 16:89CrossRef
49.
go back to reference Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890–897CrossRefPubMedPubMedCentral Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890–897CrossRefPubMedPubMedCentral
50.
go back to reference Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed
51.
go back to reference Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbates fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 9:1–8CrossRef Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbates fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 9:1–8CrossRef
52.
go back to reference Roger RR, Bonnet MH, Kramer M (1983) The relationship of sleep and anxiety in anxious subjects. Biol Psychol 16:119–126CrossRef Roger RR, Bonnet MH, Kramer M (1983) The relationship of sleep and anxiety in anxious subjects. Biol Psychol 16:119–126CrossRef
53.
go back to reference Kendall PC, Ingram RE (1987) The future for cognitive assessment of anxiety: Let’s get specific. In: Michelson L, Ascher LM (eds) Anxiety and stress disorders: Cognitive-behavioral assessment and treatment. Guilford Press, New York Kendall PC, Ingram RE (1987) The future for cognitive assessment of anxiety: Let’s get specific. In: Michelson L, Ascher LM (eds) Anxiety and stress disorders: Cognitive-behavioral assessment and treatment. Guilford Press, New York
55.
56.
go back to reference De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, Calders P, Vanderstraeten G, van de Velde D (2017) The influence of Ehlers–Danlos syndrome-hypermobility type, on motherhood: a phenomenological, hermeneutical study. Res Dev Disabil 60:135–144CrossRefPubMed De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, Calders P, Vanderstraeten G, van de Velde D (2017) The influence of Ehlers–Danlos syndrome-hypermobility type, on motherhood: a phenomenological, hermeneutical study. Res Dev Disabil 60:135–144CrossRefPubMed
57.
go back to reference Pino-Ramirez G (2016) Empowerment, life experience and Ehlers–Danlos syndrome patient associations. Cuad Neuropsicol 10:78–94 Pino-Ramirez G (2016) Empowerment, life experience and Ehlers–Danlos syndrome patient associations. Cuad Neuropsicol 10:78–94
58.
go back to reference Rubin KH, Burgess KB (2001) Social withdrawal and anxiety. In: Vasey MW, Dadds MR (eds) The developmental psychopathogy of anxiety. Oxford University Press, New York Rubin KH, Burgess KB (2001) Social withdrawal and anxiety. In: Vasey MW, Dadds MR (eds) The developmental psychopathogy of anxiety. Oxford University Press, New York
59.
go back to reference Edwards RR, Bingham CO III, Bathon J, Haythirnthwaite JA (2006) Catastrophizing and pain in Arthritis, Fibromyalgia, and other rheumatic diseases. Arthritis Rheum 55:325–332CrossRefPubMed Edwards RR, Bingham CO III, Bathon J, Haythirnthwaite JA (2006) Catastrophizing and pain in Arthritis, Fibromyalgia, and other rheumatic diseases. Arthritis Rheum 55:325–332CrossRefPubMed
60.
go back to reference Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100CrossRefPubMed Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100CrossRefPubMed
Metadata
Title
Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables
Authors
Carolina Baeza-Velasco
Caroline Bourdon
Lucile Montalescot
Cécile de Cazotte
Guillem Pailhez
Antonio Bulbena
Claude Hamonet
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 5/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4003-7

Other articles of this Issue 5/2018

Rheumatology International 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.